Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process.
Thousands of Americans are injured or die each year from adverse drug reactions, many of which are preventable. The burden of harm conveyed by the use of medications is a significant public health problem, and therefore, improving the medication-use process is a priority. Recent and ongoing efforts to improve the medication-use process have focused primarily on improving medication prescribing, and not much emphasis has been put on improving medication discontinuation. A formalized approach for rationally discontinuing medications is a necessary antecedent to improving medication safety and improving the nation's quality of care. This article proposes a conceptual framework for revising the prescribing stage of the medication-use process to include discontinuing medications. This framework has substantial practice and research implications, especially for the clinical care of older persons, who are particularly susceptible to the adverse effects of medications.
Bain
Kevin T
KT
Department of Quality Outcomes, excelleRx Inc, an Omnicare Company, Philadelphia, Pennsylvania 19102, USA. kbain@excellerx.com
Holmes
Holly M
HM
Beers
Mark H
MH
Maio
Vittorio
V
Handler
Steven M
SM
Pauker
Stephen G
SG
D000368:Aged; D000369:Aged, 80 and over; D004347:Drug Interactions; D011307:Drug Prescriptions; D004358:Drug Therapy / Q000592:standards*; D004363:Drug Utilization; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D019338:Polypharmacy; D013375:Substance Withdrawal Syndrome
Singapore Med J. 2002 Jun;43(6):279-83
12380723
JAMA. 2004 Oct 27;292(16):1955-60
15507580
Circulation. 2004 Oct 19;110(16):2333-5
15477411
Ann Intern Med. 2004 May 4;140(9):714-20
15126255
JAMA. 2007 Feb 28;297(8):831-41
17327525
JAMA. 1999 Aug 18;282(7):671-6
10517721
JAMA. 2003 Mar 5;289(9):1107-16
12622580
Am J Geriatr Pharmacother. 2006 Sep;4(3):264-72
17062328
J Am Geriatr Soc. 2007 May;55(5):734-9
17493193
Drug Saf. 2007;30(6):541-9
17536880
CNS Drugs. 2006;20(8):665-72
16863271
Control Clin Trials. 2004 Apr;25(2):168-77
15020035
CMAJ. 2003 Sep 16;169(6):549-56
12975221
BMJ. 1997 Aug 23;315(7106):464-8
9284668
Arch Intern Med. 1997 Oct 27;157(19):2205-10
9342997
Circulation. 2002 Mar 26;105(12):1446-52
11914253
JAMA. 1995 Jul 5;274(1):29-34
7791255
BMJ. 2002 Oct 12;325(7368):815
12376444
J Am Med Inform Assoc. 2007 Jan-Feb;14(1):29-40
17068355
JAMA. 2006 Dec 27;296(24):2927-38
17190893
JAMA. 2005 Dec 21;294(23):2989-95
16414946
Arch Intern Med. 2004 Oct 25;164(19):2162-8
15505131
Arch Neurol. 2001 Mar;58(3):427-33
11255446
J Am Geriatr Soc. 1993 Dec;41(12):1326-32
8227915
JAMA. 2006 Dec 27;296(24):2947-53
17190895
JAMA. 1998 Apr 15;279(15):1200-5
9555760
J Clin Psychiatry. 1997;58 Suppl 7:5-10
9219487
Neurology. 2007 Aug 28;69(9):904-10
17724294
Pharmacotherapy. 2005 Nov;25(11):1636-45
16232025